Announcement on 2024 Annual Preliminary Earnings Estimate
Filed with SSE · · 3 pages · Chinese
Shouyao Holdings Beijing Co. Ltd. on 6ix
Earlier from Shouyao Holdings Beijing
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024
- Announcement on Resolution of the 7th Meeting of the 2nd Board of Directors
- Announcement on Voluntary Disclosure of Adjustment to the Development Strategy of BTK Inhibitor SY-1530
- Report for Q3 2024
- Announcement on Voluntary Disclosure of the Acceptance of New Drug Application for the ALK inhibitor Conteltinib (CT-707)
Later from Shouyao Holdings Beijing
- Announcement on Listing and Circulation of Some Restricted Stocks in Initial Public Offering
- Announcement on Using Temporarily Idle Raised Funds for Cash Management
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Using Self-owned Funds to Pay Some Funds for Raised Fund Investment Projects and Replacing Them with an Equal Amount of Raised Funds
- Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025
Follow Shouyao Holdings Beijing into a list and get an email when it puts out news.
Follow Shouyao Holdings Beijing